SPDR S&P Pharmaceuticals ETF Rating → Protect Your Bank Account Before It’s Too Late (From Weiss Ratings) (Ad) Free XPH Stock Alerts $40.94 +0.22 (+0.54%) (As of 05/8/2024 ET) Add Compare Share Share RatingsStock AnalysisChartHeadlinesHoldingsOwnershipRatingsStock AnalysisChartHeadlinesHoldingsOwnershipRatings SPDR S&P Pharmaceuticals ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.XPH Aggregate RatingModerate Buy2.65Holdings in XPH have an aggregate rating of Moderate Buy based on 298 analyst ratings issued in the past year covering 40 companies (98.9% of the portfolio).XPH Aggregate Price Target$66.7262.97% UpsideHigh Prediction$84.19Average Prediction$66.72Low Prediction$48.42Holdings in XPH have an aggregate price target of $66.72 and a range of $48.42 to $84.19 covering 40 companies (98.9% of the portfolio).XPH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy16 Buy rating(s)Moderate Buy18 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce0 Reduce rating(s)Sell1 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by SPDR S&P Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 40 XPH Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.35%ITCIIntra-Cellular Therapies$67.00-5.9%5 of 5 stars2.90$90.17 34.6%10Earnings ReportAnalyst ForecastNews Coverage5.24%MRKMerck & Co., Inc.$129.48-0.7%5 of 5 stars2.58$131.33 1.4%125.13%PRGOPerrigo$31.11+3.2%5 of 5 stars3.00$40.67 30.7%3Earnings ReportDividend AnnouncementAnalyst DowngradeNews Coverage4.96%OGNOrganon & Co.$20.37-0.1%5 of 5 stars2.50$22.60 10.9%4Dividend Announcement4.88%CTLTCatalent$56.18-0.6%3 of 5 stars2.15$52.46 -6.6%13News Coverage4.78%AXSMAxsome Therapeutics$75.68-1.6%4 of 5 stars2.92$122.17 61.4%13Analyst ForecastAnalyst RevisionNews Coverage4.75%LLYEli Lilly and Company$775.00-0.4%5 of 5 stars2.84$757.95 -2.2%19Earnings ReportDividend Announcement4.65%VTRSViatris$11.81+0.8%0 of 5 stars1.33$11.00 -6.9%3News Coverage4.60%PFEPfizer$28.28+1.8%5 of 5 stars2.38$36.00 27.3%16Earnings ReportOptions VolumeAnalyst Revision4.59%JAZZJazz Pharmaceuticals$110.70-0.5%5 of 5 stars2.85$192.75 74.1%13Insider Selling4.55%RPRXRoyalty Pharma$27.99-1.0%5 of 5 stars3.00$46.75 67.0%4Upcoming EarningsNews Coverage4.52%JNJJohnson & Johnson$148.95+0.2%5 of 5 stars2.46$175.86 18.1%13Analyst Forecast4.29%ZTSZoetis$164.92-2.1%5 of 5 stars3.00$212.38 28.8%7Earnings ReportAnalyst ForecastAnalyst Revision4.11%BMYBristol-Myers Squibb$43.67-0.8%5 of 5 stars2.11$60.00 37.4%193.98%ELANElanco Animal Health$16.88+24.9%3 of 5 stars2.57$16.71 -1.0%7News CoverageGap UpHigh Trading Volume3.45%CORTCorcept Therapeutics$25.40+3.8%5 of 5 stars3.00$40.10 57.9%4Insider SellingAnalyst Revision2.54%ARVNArvinas$32.37-5.7%3 of 5 stars2.88$61.33 89.5%16Earnings ReportAnalyst ForecastNews CoverageGap Down2.17%SAVACassava Sciences$21.57-1.2%3 of 5 stars3.00$124.00 474.9%12.17%AMPHAmphastar Pharmaceuticals$42.21-1.3%5 of 5 stars2.50$66.00 56.4%41.97%EYPTEyePoint Pharmaceuticals$11.56-2.6%2 of 5 stars3.00$34.14 195.4%7Analyst ForecastInsider BuyingNews Coverage1.70%TARSTarsus Pharmaceuticals$37.35-1.8%3 of 5 stars2.88$48.38 29.5%8News Coverage1.47%PBHPrestige Consumer Healthcare$69.83-0.2%4 of 5 stars2.50$110.00 57.5%2Upcoming EarningsAnalyst RevisionPositive News1.25%PCRXPacira BioSciences$29.65+11.8%5 of 5 stars3.00$47.40 59.9%10Analyst ForecastNews CoverageGap UpHigh Trading Volume1.22%LBPHLongboard Pharmaceuticals$21.70-1.6%3 of 5 stars3.00$43.67 101.2%6Upcoming EarningsAnalyst Forecast1.18%HRMYHarmony Biosciences$31.70+1.1%4 of 5 stars2.50$40.63 28.2%8Positive News1.15%COLLCollegium Pharmaceutical$38.06+2.0%2 of 5 stars2.60$39.00 2.5%51.00%LQDALiquidia$12.50-2.6%3 of 5 stars2.60$21.00 68.0%5Upcoming EarningsNews CoveragePositive News0.91%SUPNSupernus Pharmaceuticals$31.30+0.5%4 of 5 stars3.00$41.00 31.0%1News Coverage0.91%AMLXAmylyx Pharmaceuticals$1.93-2.0%4 of 5 stars2.25$32.67 1,592.6%80.86%AMRXAmneal Pharmaceuticals$6.59+1.2%2 of 5 stars3.00$8.25 25.2%4Analyst Forecast0.81%LGNDLigand Pharmaceuticals$80.36+9.8%5 of 5 stars3.00$116.33 44.8%3Earnings ReportAnalyst ForecastNews Coverage0.65%ANIPANI Pharmaceuticals$65.62-1.6%5 of 5 stars3.00$80.00 21.9%4Upcoming Earnings0.58%PLRXPliant Therapeutics$13.41-2.8%4 of 5 stars3.00$45.67 240.5%10Upcoming EarningsAnalyst ForecastNews Coverage0.57%RVNCRevance Therapeutics$4.27-2.5%4 of 5 stars2.50$13.75 222.0%8Upcoming EarningsNews Coverage0.46%EOLSEvolus$13.26-1.2%4 of 5 stars3.00$20.60 55.4%3Analyst ForecastNews Coverage0.39%TBPHTheravance Biopharma$9.49-0.5%1 of 5 stars3.00$20.50 116.0%2Upcoming Earnings0.36%XERSXeris Biopharma$1.85-1.6%4 of 5 stars3.00$4.88 163.5%4Upcoming EarningsNews Coverage0.36%OCULOcular Therapeutix$5.75-3.0%4 of 5 stars3.00$17.60 206.1%6Analyst ForecastGap Down0.28%FULCFulcrum Therapeutics$7.59+0.7%2 of 5 stars2.83$13.17 73.5%6Upcoming Earnings0.06%MRNSMarinus Pharmaceuticals$1.43-8.9%4 of 5 stars2.57$13.79 864.0%7Analyst ForecastNews Coverage This page (NYSEARCA:XPH) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithGold Set to EXPLODE!Gold Safe ExchangeHow Biden has already won 2024Porter & CompanyExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SPDR S&P Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
